XML 40 R29.htm IDEA: XBRL DOCUMENT v3.21.1
Fair Value of Financial Instruments and Fair Value Measurements (Tables)
3 Months Ended
Mar. 31, 2021
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, by Balance Sheet Grouping

Fair value estimates of the Company’s financial instruments as of March 31, 2021 and December 31, 2020, including methods and assumptions utilized, are set forth below:

 

(Dollars in thousands)  As of March 31, 2021 
   Carrying                 
   amount   Level 1   Level 2   Level 3   Total 
Financial assets:                         
Cash and cash equivalents  $109,151   $109,151   $-   $-   $109,151 
Investment securities available-for-sale   320,905    20,359    300,546    -    320,905 
Bank stocks, at cost   4,062     n/a      n/a      n/a      n/a  
Loans, net   717,809    -    -    733,858    733,858 
Loans held for sale   13,995    -    13,995    -    13,995 
Accrued interest receivable   4,655    65    1,537    3,053    4,655 
Derivative financial instruments   1,757    -    1,757    -    1,757 
                          
Financial liabilities:                         
Non-maturity deposits  $(947,757)  $(947,757)  $-   $-   $(947,757)
Certificates of deposit   (123,489)   -    (123,670)   -    (123,670)
Subordinated debentures   (21,651)   -    (16,168)   -    (16,168)
Other borrowings   (4,165)   -    (4,165)   -    (4,165)
Accrued interest payable   (151)   -    (151)   -    (151)

 

   As of December 31, 2020 
   Carrying                 
   amount   Level 1   Level 2   Level 3   Total 
Financial assets:                         
Cash and cash equivalents  $84,818   $84,818   $-   $-   $84,818 
Investment securities available-for-sale   297,270    2,037    295,233    -    297,270 
Bank stocks, at cost   4,473     n/a      n/a      n/a      n/a  
Loans, net   702,782    -    -    718,071    718,071 
Loans held for sale   15,533    -    15,533    -    15,533 
Accrued interest receivable   4,885    -    1,697    3,188    4,885 
Derivative financial instruments   1,796    -    1,796    -    1,796 
                          
Financial liabilities:                         
Non-maturity deposits  $(882,277)  $(882,277)  $-   $-   $(882,277)
Certificates of deposit   (133,750)   -    (134,048)   -    (134,048)
Subordinated debentures   (21,651)   -    (15,232)   -    (15,232)
Other borrowings   (6,371)   -    (6,371)   -    (6,371)
Accrued interest payable   (168)   -    (168)   -    (168)
Derivative financial instruments   (466)   -    (466)   -    (466)
Schedule of Fair Value, Assets Measured on Recurring Basis

The following tables represent the Company’s financial instruments that are measured at fair value on a recurring basis at March 31, 2021 and December 31, 2020, allocated to the appropriate fair value hierarchy:

 

(Dollars in thousands)      As of March 31, 2021 
       Fair value hierarchy 
   Total   Level 1   Level 2   Level 3 
Assets:                    
Available-for-sale investment securities:                    
U. S. treasury securities  $20,359   $20,359   $-   $- 
U. S. federal agency obligations   18,861    -    18,861    - 
Municipal obligations, tax exempt   143,105    -    143,105    - 
Municipal obligations, taxable   41,138    -    41,138    - 
Agency mortgage-backed securities   91,987    -    91,987          - 
Certificates of deposit   5,455    -    5,455    - 
Loans held for sale   13,995    -    13,995    - 
Derivative financial instruments   1,757    -    1,757    - 

 

         As of December 31, 2020
         Fair value hierarchy 
    Total    Level 1    Level 2    Level 3 
Assets:                    
Available-for-sale investment securities:                    
U. S. treasury securities  $2,037   $2,037   $-   $- 
U. S. federal agency obligations   18,924    -    18,924    - 
Municipal obligations, tax exempt   142,676    -    142,676    - 
Municipal obligations, taxable   49,535    -    49,535    - 
Agency mortgage-backed securities   78,638    -    78,638    - 
Certificates of deposit   5,460    -    5,460    - 
Loans held for sale   15,533    -    15,533    - 
Derivative financial instruments   1,796    -    1,796    - 
Liability:                    
Derivative financial instruments   (466)   -    (466)   - 

Schedule of Fair Value Contractual Balance and Gain Loss on Loans Held for Sale

The aggregate fair value, contractual balance (including accrued interest), and gain on loans held for sale were as follows:

 

   As of   As of 
   March 31,   December 31, 
(Dollars in thousands)  2021   2020 
Aggregate fair value  $13,995   $15,533 
Contractual balance   13,956    15,151 
Gain  $39   $382 

Schedule of Gains and Losses from Changes in Fair Value of Loans Held for Sale

 

   Three months ended 
   March 31, 
(Dollars in thousands)  2021   2020 
Total change in fair value  $427   $(34)
Schedule of Fair Value Measurements on Nonrecurring, Valuation Techniques

The following table presents quantitative information about Level 3 fair value measurements measured at fair value on a nonrecurring basis as of March 31, 2021 and December 31, 2020.

 

(Dollars in thousands)              
   Fair value   Valuation technique  Unobservable inputs  Range 
As of March 31, 2021                
Impaired loans:                
Commercial real estate  $5,046   Sales comparison  Adjustment to appraised value    15%-20 %
Commercial   90   Sales comparison  Adjustment to comparable sales   0%-86%
Agriculture   11   Sales comparison  Adjustment to appraised value   25%
                 
As of December 31, 2020                
Impaired loans:                
Commercial real estate  $3,640   Sales comparison  Adjustment to appraised value   20%
Commercial   74   Sales comparison  Adjustment to comparable sales   0%-69%
Agriculture   9   Sales comparison  Adjustment to appraised value   20%
Real estate owned:                
One-to-four family residential real estate   48   Sales comparison  Adjustment to appraised value   10%